World Anti Angiogenesis Summit
|Event Date/Time: Jan 24, 2011||End Date/Time: Jan 26, 2011|
We've already seen the success of Genentech's Avastin, but where's the next blockbuster anticancer drug going to come from?
With an exciting number of antiangiogenic agents in both preclinical and clinical development, you've told us there's no better time for the industry to come together and discuss the most crucial challenges currently preventing angiogenesis inhibitors from unleashing their full potential to fight cancer. You could be joining our angiogenesis and oncology R&D leaders (listed at the top of this page) at the World Anti-Angiogenesis Summit, January 24th-26th 2011 in Boston, MA to find out how you can best harness current angiogenesis research for clinical and commercial success. That's the name of the game at this meeting.